| 0 |
TICK-BORNE VIRAL ENCEPHALITIS |
3 |
0.0500 |
| 1 |
VIITH NERVE INJURY |
1 |
0.0123 |
| 2 |
PARAPSORIASIS |
2 |
0.0074 |
| 3 |
ARTERIAL DISORDER |
6 |
0.0031 |
| 4 |
PARAKERATOSIS |
1 |
0.0031 |
| 5 |
ACANTHOSIS |
1 |
0.0030 |
| 6 |
SOFT TISSUE MASS |
1 |
0.0022 |
| 7 |
EXCESSIVE GRANULATION TISSUE |
1 |
0.0012 |
| 8 |
TEMPORAL ARTERITIS |
1 |
0.0011 |
| 9 |
LYMPHOCYTIC INFILTRATION |
1 |
0.0010 |
| 10 |
BRAIN DEATH |
3 |
0.0010 |
| 11 |
HYPOPERFUSION |
1 |
0.0010 |
| 12 |
IATROGENIC INJURY |
1 |
0.0008 |
| 13 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
2 |
0.0007 |
| 14 |
MYOGLOBIN BLOOD INCREASED |
1 |
0.0007 |
| 15 |
SINUS ARREST |
1 |
0.0006 |
| 16 |
BRADYARRHYTHMIA |
1 |
0.0006 |
| 17 |
TROPONIN I INCREASED |
1 |
0.0006 |
| 18 |
ARTERIAL THROMBOSIS |
1 |
0.0005 |
| 19 |
POLYCYTHAEMIA |
1 |
0.0005 |
| 20 |
EXPOSURE VIA INGESTION |
1 |
0.0004 |
| 21 |
DIASTOLIC DYSFUNCTION |
1 |
0.0003 |
| 22 |
BLEPHAROSPASM |
2 |
0.0003 |
| 23 |
BRADYPHRENIA |
2 |
0.0003 |
| 24 |
POTENTIATING DRUG INTERACTION |
1 |
0.0003 |
| 25 |
EXTRAVASATION |
1 |
0.0002 |
| 26 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
| 27 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 28 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 29 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 30 |
HYPERKERATOSIS |
1 |
0.0002 |
| 31 |
REBOUND EFFECT |
2 |
0.0002 |
| 32 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 33 |
VISUAL DISTURBANCE |
1 |
0.0002 |
| 34 |
ATAXIA |
2 |
0.0002 |
| 35 |
BRAIN OEDEMA |
2 |
0.0002 |
| 36 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 37 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 38 |
COORDINATION ABNORMAL |
2 |
0.0001 |
| 39 |
CARDIOGENIC SHOCK |
2 |
0.0001 |
| 40 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 41 |
PEMPHIGOID |
1 |
0.0001 |
| 42 |
COMPLETED SUICIDE |
11 |
0.0001 |
| 43 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 44 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 45 |
POISONING DELIBERATE |
1 |
0.0001 |
| 46 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 47 |
EYELID PTOSIS |
1 |
0.0001 |
| 48 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 49 |
INTENTIONAL DRUG MISUSE |
2 |
0.0001 |
| 50 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 51 |
GAIT INABILITY |
3 |
0.0001 |
| 52 |
POISONING |
1 |
0.0001 |
| 53 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 54 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 55 |
APHASIA |
2 |
0.0001 |
| 56 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 57 |
ARRHYTHMIA |
3 |
0.0001 |
| 58 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 59 |
CARDIAC ARREST |
5 |
0.0001 |
| 60 |
COAGULOPATHY |
1 |
0.0001 |
| 61 |
FACE OEDEMA |
1 |
0.0001 |
| 62 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 63 |
TOXICITY TO VARIOUS AGENTS |
9 |
0.0001 |
| 64 |
DYSARTHRIA |
2 |
0.0001 |
| 65 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 66 |
DISORIENTATION |
2 |
0.0001 |
| 67 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 68 |
OSTEOPOROSIS |
2 |
0.0000 |
| 69 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 70 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 71 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 72 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 73 |
LEUKOPENIA |
2 |
0.0000 |
| 74 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 75 |
DEHYDRATION |
5 |
0.0000 |
| 76 |
SKIN LESION |
1 |
0.0000 |
| 77 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 78 |
PANCYTOPENIA |
2 |
0.0000 |
| 79 |
ANGINA PECTORIS |
1 |
0.0000 |
| 80 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 81 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 82 |
HIP FRACTURE |
1 |
0.0000 |
| 83 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 84 |
HYPOTENSION |
6 |
0.0000 |
| 85 |
HYPERKALAEMIA |
1 |
0.0000 |
| 86 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 87 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 88 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 89 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 90 |
HYPOACUSIS |
1 |
0.0000 |
| 91 |
BALANCE DISORDER |
2 |
0.0000 |
| 92 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 93 |
CELLULITIS |
1 |
0.0000 |
| 94 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 95 |
NERVOUSNESS |
1 |
0.0000 |
| 96 |
ASTHENIA |
7 |
0.0000 |
| 97 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 98 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 99 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 100 |
CHILLS |
2 |
0.0000 |
| 101 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 102 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 103 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 104 |
VISION BLURRED |
2 |
0.0000 |
| 105 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 106 |
AGITATION |
1 |
0.0000 |
| 107 |
DRUG INTERACTION |
2 |
0.0000 |
| 108 |
DIZZINESS |
6 |
0.0000 |
| 109 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 110 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 111 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 112 |
SWELLING |
1 |
0.0000 |
| 113 |
ANAEMIA |
2 |
0.0000 |
| 114 |
SOMNOLENCE |
2 |
0.0000 |
| 115 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 116 |
OVERDOSE |
2 |
0.0000 |
| 117 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 118 |
HYPERHIDROSIS |
1 |
0.0000 |
| 119 |
RENAL FAILURE |
1 |
0.0000 |
| 120 |
INSOMNIA |
2 |
0.0000 |
| 121 |
HYPOAESTHESIA |
1 |
0.0000 |
| 122 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 123 |
DRUG INEFFECTIVE |
8 |
0.0000 |
| 124 |
FALL |
2 |
0.0000 |
| 125 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 126 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 127 |
PYREXIA |
2 |
0.0000 |
| 128 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 129 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 130 |
ERYTHEMA |
1 |
0.0000 |
| 131 |
HEADACHE |
3 |
0.0000 |
| 132 |
HYPERTENSION |
1 |
0.0000 |
| 133 |
MALAISE |
2 |
0.0000 |
| 134 |
WEIGHT INCREASED |
1 |
0.0000 |
| 135 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 136 |
VOMITING |
2 |
0.0000 |
| 137 |
NAUSEA |
3 |
0.0000 |
| 138 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 139 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 140 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 141 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 142 |
PAIN |
2 |
0.0000 |
| 143 |
DIARRHOEA |
2 |
0.0000 |
| 144 |
PNEUMONIA |
1 |
0.0000 |
| 145 |
FATIGUE |
2 |
0.0000 |
| 146 |
DEATH |
1 |
0.0000 |
| 147 |
OFF LABEL USE |
1 |
0.0000 |